aqst stock forecast fda approval

Friday, November 11, 2022 Edit

Real-time trade and investing ideas on Aquestive Therapeutics Inc AQST from the largest community of traders and investors. Its product pipeline include Libervant AQST-108 AQST-305 Suboxone and Zuplenz.

Fda Tradingview

In this video I talk about Aquestic Therapeutics and the opportunity that lies in front of us with their pipeline product Libervant that is awaiting FDA ap.

. Aquestive Therapeutics Receives FDA Tentative Approval for Libervant TM diazepam Buccal Film. AQST FDAAPROVAL ZACHLYTRADES Aquestive Therapeutics is approaching an important FDA decision in December today I am going to give you stock price targets. The active programs in its complex molecule pipeline portfolio are.

Libervant provided tentative approval from. Libervant was granted Orphan Drug Designation by the FDA in November 2016. 46019 Upside Based on 6 Wall Street analysts offering 12 month price targets for Aquestive Therapeutics in the last 3 months.

Aquestive which is focused on the development and commercialization of products with its PharmFilm technology for anaphylaxis and epilepsy currently has five FDA. The 7 analysts offering 12-month price forecasts for Aquestive Therapeutics Inc have a median target of 500 with a high estimate of 950 and a low estimate. AQST-109 is a polymer matrix-based film that can be applied sublingually under the tongue.

AQST-109-SF AQST-108-SF and AQST-108-SF. Is Aquestive Therapeutics Stock Undervalued. The company was founded in January 2004 and is headquartered in Warren NJ.

Companies disclose these risks in their yearly. The current Aquestive Therapeutics share price is 101. August 31 2022 - 800 am.

AQST a company focused on different formulations of drugs announced Wednesday that the FDA granted tentative approval for. Aquestive Therapeutics NASDAQ. Rooms Rankings Earnings Newsletters.

Its PharmFilm technology develops medicines that offer non-invasive. These disclosures are known as Risk Factors. Public companies are required to disclose risks that can affect the business and impact the stock.

The average price target. AQST Stock Price Prediction. The Score for AQST is 25 which is 50 below its historic median score of 50 and infers.

Aqst 20211231